PRO-DEX, INC. (PDEX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD (m); Retained Earnings (Accumulated Deficit)USD $47.63M; Stockholders' Equity Attributable to ParentUSD $47.63M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
- 2026-03-31: Common Stock, Value, IssuedUSD (m); Retained Earnings (Accumulated Deficit)USD $45.20M; Stockholders' Equity Attributable to ParentUSD $45.20M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
- 2025-12-31: Common Stock, Value, IssuedUSD (m); Retained Earnings (Accumulated Deficit)USD $41.63M; Stockholders' Equity Attributable to ParentUSD $41.61M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
- 2025-09-30: Common Stock, Value, IssuedUSD $905.00K; Retained Earnings (Accumulated Deficit)USD $40.61M; Stockholders' Equity Attributable to ParentUSD $41.51M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD (m).
PRO-DEX, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | $47.63M | $47.63M | (m) | (m) |
| 2026-03-31 | (m) | $45.20M | $45.20M | (m) | (m) |
| 2025-12-31 | (m) | $41.63M | $41.61M | (m) | (m) |
| 2025-09-30 | $905.00K | $40.61M | $41.51M | (m) | (m) |
| 2025-06-30 | $704.00K | $35.93M | $36.63M | (m) | (m) |
| 2025-03-31 | $551.00K | $34.73M | $35.28M | (m) | (m) |
| 2024-12-31 | $366.00K | $31.46M | $31.82M | (m) | (m) |
| 2024-09-30 | $1.46M | $29.42M | $30.88M | (m) | (m) |
| 2024-06-30 | $3.92M | $26.95M | $30.87M | (m) | (m) |
| 2024-03-31 | $5.58M | $25.36M | $30.94M | (m) | (m) |
| 2023-12-31 | $7.08M | $24.71M | $31.79M | (m) | (m) |
| 2023-09-30 | $6.99M | $24.21M | $31.20M | (m) | (m) |
| 2023-06-30 | $6.77M | $24.82M | $31.59M | (m) | (m) |
| 2023-03-31 | $6.58M | $23.32M | $29.91M | (m) | (m) |
| 2022-12-31 | $6.53M | $21.70M | $0.00 | (m) | (m) |
| 2022-09-30 | $7.35M | $18.95M | $26.31M | (m) | (m) |
| 2022-06-30 | $7.68M | $17.75M | $25.43M | (m) | (m) |
| 2022-03-31 | $7.69M | $15.91M | $22.27M | (m) | (m) |
| 2021-12-31 | $7.89M | $15.34M | $22.00M | (m) | (m) |
| 2021-09-30 | $8.19M | $14.26M | $21.38M | (m) | (m) |
| 2021-06-30 | $7.95M | $12.13M | $21.13M | $-215.00K | (m) |
| 2021-03-31 | $9.06M | $12.07M | $20.41M | $-144.00K | (m) |
| 2020-12-31 | $12.62M | $9.91M | $21.84M | $-280.00K | (m) |
| 2020-09-30 | $12.58M | $8.12M | $20.05M | $-1.69M | (m) |
| 2020-06-30 | $12.75M | $7.90M | $19.06M | $-1.59M | (m) |
| 2020-03-31 | $12.97M | $5.35M | $17.16M | $-1.16M | (m) |
| 2019-12-31 | $13.63M | $4.14M | $17.87M | $100.00K | (m) |
| 2019-09-30 | $15.16M | $2.89M | $17.44M | $-606.00K | (m) |
| 2019-06-30 | $15.81M | $1.74M | $17.01M | $-549.00K | (m) |
| 2019-03-31 | $17.12M | $854.00K | $17.65M | $-316.00K | (m) |
| 2018-12-31 | $17.21M | $122.00K | $16.98M | $-349.00K | (m) |
| 2018-09-30 | $18.64M | $-1.06M | $17.73M | $145.00K | (m) |
| 2018-06-30 | $19.84M | $-2.41M | $17.28M | $-153.00K | (m) |
| 2018-03-31 | $20.03M | $-2.57M | $17.43M | $-31.00K | (m) |
| 2018-03-01 | (m) | (m) | $17.43M | (m) | (m) |
| 2017-12-31 | $19.89M | $-3.05M | $16.74M | $-90.00K | (m) |
| 2017-09-30 | $19.75M | $-3.40M | $16.27M | $-76.00K | (m) |
| 2017-06-30 | $17.70M | $-4.03M | $13.71M | $33.00K | (m) |
| 2017-03-31 | $17.70M | $-4.74M | $12.96M | (m) | (m) |
| 2016-12-31 | $17.84M | $-5.63M | $12.20M | $-6.00K | (m) |
| 2016-09-30 | $17.95M | $-8.82M | $9.13M | (m) | (m) |
| 2016-06-30 | $17.99M | $-9.11M | $8.88M | (m) | (m) |
| 2016-03-31 | $18.44M | $-9.30M | $9.14M | (m) | (m) |
| 2015-12-31 | $18.43M | $-9.67M | $8.77M | (m) | (m) |
| 2015-09-30 | $18.42M | $-10.06M | $8.36M | (m) | (m) |
| 2015-06-30 | $18.41M | $-9.93M | $8.48M | (m) | (m) |
| 2015-03-31 | $18.41M | $-10.01M | $8.40M | (m) | (m) |
| 2014-12-31 | $18.50M | $-9.93M | $8.88M | $316.00K | (m) |
| 2014-09-30 | $18.59M | $-9.74M | $9.06M | $213.00K | (m) |
| 2014-06-30 | $18.58M | $-9.57M | $9.22M | $202.00K | $9.22M |
| 2014-03-31 | $17.06M | $-9.59M | $7.67M | $202.00K | (m) |
| 2013-12-31 | $17.04M | $-9.21M | $8.05M | $209.00K | (m) |
| 2013-09-30 | $17.03M | $-8.87M | $8.22M | $61.00K | (m) |
| 2013-06-30 | $17.01M | $-9.08M | $7.94M | $5.00K | $7.94M |
| 2013-03-31 | $17.00M | $-8.41M | $8.60M | (m) | (m) |
| 2012-12-31 | $16.96M | $-7.66M | $9.30M | (m) | (m) |
| 2012-09-30 | $16.88M | $-7.31M | $9.56M | (m) | (m) |
| 2012-06-30 | $16.85M | $-7.30M | $9.55M | (m) | $9.55M |
| 2012-03-31 | $16.82M | $-6.75M | $10.06M | (m) | (m) |
| 2011-12-31 | $16.78M | $-6.27M | $10.51M | (m) | (m) |
| 2011-09-30 | $16.76M | $-5.97M | $10.78M | (m) | (m) |
| 2011-06-30 | $16.74M | $-6.42M | $10.32M | (m) | $10.32M |
| 2010-06-30 | (m) | (m) | $7.62M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |